论文信息 - Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. - 字舞流文

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.

E. Jonasch | S. Matin | Michelle D. Williams | L. Santarpia | N. Perrier | M. Cabanillas | S. Waguespack | R. Nunez | T. Rich | K. Kyle | C. Jimenez | A. Phan | Elizabeth A. Lano | B. Shah | M. Williams | E. Lano